Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 10/1/15  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Neil L. Berinstein MD

Wrong Dr. Neil L. Berinstein MD?

Director of Translational Researc...

Phone: (647) ***-****  
Ontario Institute for Cancer Research
MaRS Centre, 661 University Avenue, Suite 510
Toronto , Ontario m5g 0a3
Canada

Company Description: The Ontario Institute for Cancer Research (OICR) is a centre of excellence in cancer research with a focus on prevention, early detection, diagnosis and treatment...   more
Background

Employment History

Board Memberships and Affiliations

Education

  • M.D. , Department of Medicine
  • Medical Doctoral Degree
    University of Manitoba
  • Internal Medicine and Medical Oncology
    University of Toronto
  • MD
    University of Manitoba
126 Total References
Web References
Neil Berinstein, ...
www.newevidence.com, 1 Oct 2015 [cached]
Neil Berinstein, MD Dr. Neil Berinstein earned his pre-medical degree and Medical Doctorate from the University of Manitoba and received further specialty and research training at the University of Toronto and Stanford University. Dr. Berinstein currently holds multiple academic and professional positions, including as a Professor in the Department of Medicine at the University of Toronto, and he is on the active staff of the Hematology Oncology Site Group at the Odette Cancer Centre of the Sunnybrook Health Sciences Centre. He is currently the Director of Translational Research at the Ontario Institute for Cancer Research. Dr. Berinstein specializes in the management and research of patients with lymphoproliferative disorders, including non-Hodgkin lymphoma, chronic lymphocytic leukemia, Hodgkin lymphoma, and myeloma. Dr. Berinstein has received numerous grants throughout his career for his research, which focuses on the development of novel immunotherapeutic and targeted approaches for cancer and hematologic malignancies. He has published six book chapters and over 100 peer-reviewed, invited, or review papers.
Immunovaccine : Science Advisory
www.imvaccine.com, 12 Oct 2014 [cached]
Dr. Neil Berinstein
...
Dr. Neil Berinstein Science Advisory Board
Dr. Berinstein obtained his Medical Doctoral Degree at the University of Manitoba and completed training programs at the University of Toronto in Internal Medicine and Medical Oncology and at Stanford University in the area of Immunotherapy for cancer. Dr. Berinstein was a founding director of the Advanced Therapeutics Program at the Toronto-Sunnybrook Regional Cancer Centre with a long track record in fundamental research and a significant publication record in the area of normal and malignant B cell biology and cancer immunotherapy. Dr. Berinstein was Global Program Head of Sanofi Pasteur's cancer vaccine program from 1998-2009. He is a Full Professor in the Department of Medicine at the University of Toronto and is currently the Director of Translational Research at the Ontario Institute for Cancer Research. He is a member of the Executive Committee of the Cancer Research Institute Cancer Immunotherapy Consortium. He has published over 100 research papers and a similar number of research abstracts.
Cancer Immunotherapy Consortium of the Cancer Research Institute - CRI
www.cancerresearch.org, 18 May 2014 [cached]
Neil L. Berinstein, M.D.
Ontario Institute for Cancer Research
Neil L. Berinstein, ...
www.cancerresearch.org, 18 May 2014 [cached]
Neil L. Berinstein, M.D. Cancer Immunotherapy Consortium of the Cancer Research Institute - CRI Cancer Research Institute Logo
...
Neil L. Berinstein, M.D.
...
Neil L. Berinstein, M.D., has recently joined the Ontario Institute for Cancer Research as director of translation research and is helping to develop novel oncolytic virus and cancer vaccine approaches for the treatment of cancer. Previously, he was chief scientific officer at IRX Therapeutics and led the pre-clinical and clinical research program around the IRX2 immunomodulator. He was assistant vice president and global program leader at Sanofi Pasteur, where he was in charge of leading the development of Sanofi's cancer vaccines, both strategically and operationally. Dr. Berinstein was responsible for interacting with international collaborators and leading researchers who were collaborating with Sanofi Pasteur, either at pre-clinical or clinical levels. He saw to completion several multicenter phase I and phase II studies in Canada and the U.S. in colorectal and melanoma projects. He is a scientific advisor for several cancer biotechnology companies including Immunovaccine, Biovest, and Spectrum.
Dr. Berinstein currently holds multiple academic and professional positions, including professor in the department of medicine at the University of Toronto, and as an active staff member at the Odette Cancer Center of the Sunnybrook Health Science Center. He was the vice president of the Cancer Vaccine Consortium, sponsored by the Sabin Vaccine Institute, and more recently, is part of the executive steering committee of the Cancer Research Institute (CRI)-sponsored Cancer Immunotherapy Consortium. He was also formerly a member and leader of the scientific review committee of the Leukemia Research Fund.
Dr. Berinstein is the recipient of numerous grants in his research career and has published six book chapters, and over 100 peer-reviewed, invited, or review papers to date. He received his pre-medical degree and Medical Doctorate from University of Manitoba and further specialty and research training at the University of Toronto and Stanford University.
Scientific Advisory Board
www.biovest.com, 9 Dec 2013 [cached]
Neil L. Berinstein, M.D., Professor of Medicine, University of Toronto and Director of Translational Research, Ontario Institute for Cancer Research - Dr. Berinstein is a global pioneer in cancer vaccines, having formerly served as Assistant Vice President and Global Program Leader at Sanofi Pasteur, leading the development of Sanofi's cancer vaccines both strategically and operationally. He currently serves as part of the Executive Steering Committee of the Cancer Research Institute-sponsored Cancer Immunotherapy Consortium and was formerly a member and leader of the scientific review committee of the Leukemia Research Fund. Dr. Berinstein is the recipient of numerous grants in his research career and has published six book chapters, and over 100 peer-reviewed, invited or review papers to date.
Other People with the name "Berinstein":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.